Results 131 to 140 of about 44,284 (201)

Identification of Bioactive Compound From Microalga BTM 11 as Hepatitis C Virus RNA Helicase Inhibitor [PDF]

open access: yes, 2015
Hepatitis C virus (HCV) is the major causative agent of chronic liver disease. Recently, the inhibition of NS3 RNA helicase/ATPase activity is being explored as the specifically targeted antiviral therapy (STAT) against HCV infection.
Farida, H. (Hilda)   +4 more
core  

Association between Different Hepatitis C Virus Genotypes Infection and Type-2 Diabetes Mellitus: A Descriptive-Analytical Study from the Northwest of Iran

open access: yesJournal of Medical Microbiology and Infectious Diseases, 2020
Introduction: Hepatitis C virus (HCV) infection and type 2 Diabetes Mellitus (T2DM) are among the severe threats to health care systems worldwide. Here, we investigated the association of HCV genotypes and cirrhosis with T2DM among HCV-positive patients.
Parviz Saleh   +4 more
doaj  

Hepacivirus / hepatocyte interplay leading to liver metabolic disorders

open access: yes, 2023
L'hépatite C chronique est une maladie progressive du foie, entraînant la stéatose, une accumulation anormale de lipides, ainsi qu'une cirrhose et un carcinome hépatocellulaire (CHC) à long terme. La prévalence de ces manifestations varie selon le génotype (Gt) viral, le Gt3 étant très fortement associé à la stéatose.
openaire   +1 more source

17th European College of Equine Internal Medicine (ECEIM) Congress Copenhagen, Denmark 14‐16 November 2024

open access: yes
Journal of Veterinary Internal Medicine, Volume 39, Issue 1, January/February 2025.
wiley   +1 more source

Nuevos fármacos antivirales de acción directa en una población atendida por una unidad de enfermedades infecciosas. Estudio descriptivo [PDF]

open access: yes, 2017
La hepatitis C es una enfermedad infecciosa que afecta principalmente al hígado y está causada por un virus RNA de cadena positiva perteneciente a la familia Flaviviridae, género Hepacivirus, del que se conocen 7 genotipos, el último descrito ...
Gutiérrez Vélez, Rebeca
core  

Противовирусные лекарственные средства для лечения гепатита C [PDF]

open access: yes, 2019
ГЕПАТИТ C /ЛЕК ТЕРПАРЕНТЕРАЛЬНО-ПЕРЕДАВАЕМЫЙ ГЕПАТИТ НИ-A, НИ-B /ЛЕК ТЕРПРОТИВОВИРУСНЫЕ СРЕДСТВА /ХИМЛЕКАРСТВ ХИМИЧЕСКАЯ СТАБИЛЬНОСТЬИНГИБИТОРЫ ПРОТЕАЗЫ NS3/NS4АИНГИБИТОРЫ БЕЛКА NS5AИНГИБИТОРЫ NS5B ПОЛИМЕРАЗЫДан обзор химической структуры и её связи с ...
Жерносек, А. К.   +1 more
core  

Identification of claudin-3 as an entry factor for rat hepacivirus. [PDF]

open access: yesProc Natl Acad Sci U S A
Tanaka T   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy